A highly effective reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 infection.
A highly effective reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 infection.
复制标题
DOI:
10.1016/j.jinf.2020.10.039
复制
发表时间:
2021-01
期刊:
影响因子:
--
通讯作者:
Kidd SP
中科院分区:
文献类型:
--
作者:
Fowler VL;Armson B;Gonzales JL;Wise EL;Howson ELA;Vincent-Mistiaen Z;Fouch S;Maltby CJ;Grippon S;Munro S;Jones L;Holmes T;Tillyer C;Elwell J;Sowood A;de Peyer O;Dixon S;Hatcher T;Patrick H;Laxman S;Walsh C;Andreou M;Morant N;Clark D;Moore N;Houghton R;Cortes NJ;Kidd SP
The COVID-19 pandemic has illustrated the importance of simple, rapid and accurate diagnostic testing. This study describes the validation of a new rapid SARS-CoV-2 RT-LAMP assay for use on extracted RNA or directly from swab offering an alternative diagnostic pathway that does not rely on traditional reagents that are often in short supply during a pandemic. Analytical specificity (ASp) of this new RT-LAMP assay was 100% and analytical sensitivity (ASe) was between 1 × 101 and 1 × 102 copies per reaction when using a synthetic DNA target. The overall diagnostic sensitivity (DSe) and specificity (DSp) of RNA RT-LAMP was 97% and 99% respectively, relative to the standard of care rRT-PCR. When a CT cut-off of 33 was employed, above which increasingly evidence suggests there is a low risk of patients shedding infectious virus, the diagnostic sensitivity was 100%. The DSe and DSp of Direct RT-LAMP (that does not require RNA extraction) was 67% and 97%, respectively. When setting CT cut-offs of ≤33 and ≤25, the DSe increased to 75% and 100%, respectively, time from swab-to-result, CT < 25, was < 15 min. We propose that RNA RT-LAMP could replace rRT-PCR where there is a need for increased sample throughput and Direct RT-LAMP as a near-patient screening tool to rapidly identify highly contagious individuals within emergency departments and care homes during times of increased disease prevalence ensuring negative results still get laboratory confirmation.
登录
查看更多内容
影响因子:
2.7
作者:
Abbasi I;Kirstein OD;Hailu A;Warburg A
通讯作者:
Warburg A
影响因子:
28.3
作者:
Gorbalenya, Alexander E.;Baker, Susan C.;Ziebuhr, John
通讯作者:
Ziebuhr, John
影响因子:
3.1
作者:
Fowler, Veronica L.;Howson, Emma L. A.;King, Donald P.
通讯作者:
King, Donald P.
影响因子:
11.8
作者:
Bullard, Jared;Dust, Kerry;Poliquin, Guillaume
通讯作者:
Poliquin, Guillaume
DOI:
10.1007/s10096-020-03913-9
发表时间:
2020-04-27
影响因子:
4.5
作者:
La Scola, Bernard;Le Bideau, Marion;Raoult, Didier
通讯作者:
Raoult, Didier